142 related articles for article (PubMed ID: 29706487)
1. Acetylcholinesterase inhibitors and risk of stroke and death in people with dementia.
Tan ECK; Johnell K; Garcia-Ptacek S; Haaksma ML; Fastbom J; Bell JS; Eriksdotter M
Alzheimers Dement; 2018 Jul; 14(7):944-951. PubMed ID: 29706487
[TBL] [Abstract][Full Text] [Related]
2. Do Acetylcholinesterase Inhibitors Prevent or Delay Psychotropic Prescribing in People With Dementia? Analyses of the Swedish Dementia Registry.
Tan ECK; Johnell K; Bell JS; Garcia-Ptacek S; Fastbom J; Nordström P; Eriksdotter M
Am J Geriatr Psychiatry; 2020 Jan; 28(1):108-117. PubMed ID: 31331724
[TBL] [Abstract][Full Text] [Related]
3. Association between acetylcholinesterase inhibitors and risk of stroke in patients with dementia.
Lin YT; Wu PH; Chen CS; Yang YH; Yang YH
Sci Rep; 2016 Jul; 6():29266. PubMed ID: 27377212
[TBL] [Abstract][Full Text] [Related]
4. Statins, Risk of Death and Ischemic Stroke in Patients with Dementia: A Registry-Based Observational Cohort Study.
Petek B; Xu H; Villa-Lopez M; Winblad B; Kramberger MG; Eriksdotter M; Garcia-Ptacek S
Curr Alzheimer Res; 2020; 17(10):881-892. PubMed ID: 33327915
[TBL] [Abstract][Full Text] [Related]
5. Impact of acetylcholinesterase inhibitors on the occurrence of acute coronary syndrome in patients with dementia.
Wu PH; Lin YT; Hsu PC; Yang YH; Lin TH; Huang CT
Sci Rep; 2015 Nov; 5():15451. PubMed ID: 26577589
[TBL] [Abstract][Full Text] [Related]
6. Stroke as a Cause of Death in Death Certificates of Patients with Dementia: A Cohort Study from the Swedish Dementia Registry.
Subic A; Zupanic E; von Euler M; Norrving B; Cermakova P; Religa D; Winblad B; Kramberger MG; Eriksdotter M; Garcia-Ptacek S
Curr Alzheimer Res; 2018; 15(14):1322-1330. PubMed ID: 30280666
[TBL] [Abstract][Full Text] [Related]
7. Anticholinergic Burden and Risk of Stroke and Death in People with Different Types of Dementia.
Tan ECK; Eriksdotter M; Garcia-Ptacek S; Fastbom J; Johnell K
J Alzheimers Dis; 2018; 65(2):589-596. PubMed ID: 30056424
[TBL] [Abstract][Full Text] [Related]
8. Acetylcholinesterase Inhibitors Are Associated with Reduced Fracture Risk among Older Veterans with Dementia.
Ogunwale AN; Colon-Emeric CS; Sloane R; Adler RA; Lyles KW; Lee RH
J Bone Miner Res; 2020 Mar; 35(3):440-445. PubMed ID: 31711264
[TBL] [Abstract][Full Text] [Related]
9. Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer's disease: a retrospective survival analysis.
Mueller C; Perera G; Hayes RD; Shetty H; Stewart R
Age Ageing; 2018 Jan; 47(1):88-94. PubMed ID: 28655175
[TBL] [Abstract][Full Text] [Related]
10. Pre-Stroke Cholinesterase Inhibitor Treatment Is Beneficially Associated with Functional Outcome in Patients with Acute Ischemic Stroke and Pre-Stroke Dementia: The Fukuoka Stroke Registry.
Wakisaka Y; Matsuo R; Nakamura K; Ago T; Kamouchi M; Kitazono T;
Cerebrovasc Dis; 2021; 50(4):390-396. PubMed ID: 33744892
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Outcomes of Cholinesterase Inhibitors in Individuals with Dementia: A Meta-Analysis and Systematic Review.
Isik AT; Soysal P; Stubbs B; Solmi M; Basso C; Maggi S; Schofield P; Veronese N; Mueller C
J Am Geriatr Soc; 2018 Sep; 66(9):1805-1811. PubMed ID: 29851022
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with response to acetylcholinesterase inhibition in dementia: a cohort study from a secondary mental health care case register in london.
Perera G; Khondoker M; Broadbent M; Breen G; Stewart R
PLoS One; 2014; 9(11):e109484. PubMed ID: 25411838
[TBL] [Abstract][Full Text] [Related]
13. Causes of Death According to Death Certificates in Individuals with Dementia: A Cohort from the Swedish Dementia Registry.
Garcia-Ptacek S; Kåreholt I; Cermakova P; Rizzuto D; Religa D; Eriksdotter M
J Am Geriatr Soc; 2016 Nov; 64(11):e137-e142. PubMed ID: 27801938
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry.
Secnik J; Schwertner E; Alvarsson M; Hammar N; Fastbom J; Winblad B; Garcia-Ptacek S; Religa D; Eriksdotter M
BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958305
[TBL] [Abstract][Full Text] [Related]
15. The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease.
Nordström P; Religa D; Wimo A; Winblad B; Eriksdotter M
Eur Heart J; 2013 Sep; 34(33):2585-91. PubMed ID: 23735859
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholinesterase inhibitors reduce spreading activation in dementia.
Foster PS; Branch KK; Witt JC; Giovannetti T; Libon D; Heilman KM; Drago V
Neuropsychologia; 2012 Jul; 50(8):2093-9. PubMed ID: 22609576
[TBL] [Abstract][Full Text] [Related]
17. Depression, stroke, and dementia in patients with myocardial infarction.
Sundbøll J
Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619929
[TBL] [Abstract][Full Text] [Related]
18. Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
Saint-Laurent Thibault C; Özer Stillman I; Chen S; Getsios D; Proskorovsky I; Hernandez L; Dixit S
J Med Econ; 2015; 18(11):930-43. PubMed ID: 26086535
[TBL] [Abstract][Full Text] [Related]
19. Use of antipsychotics, benzodiazepine derivatives, and dementia medication among older people with intellectual disability and/or autism spectrum disorder and dementia.
Axmon A; Kristensson J; Ahlström G; Midlöv P
Res Dev Disabil; 2017 Mar; 62():50-57. PubMed ID: 28110116
[TBL] [Abstract][Full Text] [Related]
20. Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14,529 patients in the Swedish Stroke Register.
Asberg S; Henriksson KM; Farahmand B; Asplund K; Norrving B; Appelros P; Stegmayr B; Asberg KH; Terént A
Stroke; 2010 Jul; 41(7):1338-42. PubMed ID: 20522818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
